Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The novel zinc finger pseudogene (ENSG00000275547) is a noncoding DNA segment in the human genome that has sequence similarity to genes encoding zinc finger proteins, specifically those involved in DNA binding and gene regulation[1][7]. Classified as a "pseudogene," it does not encode a functional protein and lacks the necessary elements for transcription and translation, such as a suitable promoter region[2][8]. Zinc finger pseudogenes typically arise through retrotransposition or duplication events, which copy and disable protein-coding genes during evolution[8][3]. While most pseudogenes are biologically inactive, some may display residual transcription or exert subtle regulatory influences; however, there is no evidence to suggest therapeutic significance for ENSG00000275547[1][8]. This entry refers specifically to a nonfunctional gene segment resembling the zinc finger protein family but should not be considered a valid therapeutic or research target.
None (no drug mechanisms are relevant)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel zinc finger pseudogene (ENSG00000275547).